Updates are available Correction dated 2022-10-21

Article History

Accepted: 29 August 2022

First Online: 22 September 2022

Change Date: 21 October 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40258-022-00768-3

Declarations

:

: This study was partially funded by an unrestricted research grant from Medipost Co., Ltd (the manufacturer of Cartistem), South Korea. The funding source did not have any role in the study design, collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.

: The authors declare that they have no conflict of interest to disclose.

: The datasets used and/or analyzed during the present study are available from the corresponding author upon reasonable request.

: The model used for the present study is available from the corresponding author upon reasonable request.

: KS contributed to the study conception and design, data collection, analysis and interpretation of the data, and manuscript development. BJC, AG, SML CWH, DCS, and MKK participated in data collection and analysis and writing the draft manuscript. DCS, HC, GYH, and SML performed the cost-effectiveness analysis and simulation. KS and SML had full access to all the data in the study and take responsibility for the integrity of the work as a whole. All authors contributed to the final manuscript’s writing, editing, and approval.

: Not applicable.

: Not applicable.

: Not applicable.